When.com Web Search

  1. Ads

    related to: checkpoint inhibitor for colitis

Search results

  1. Results From The WOW.Com Content Network
  2. Checkpoint inhibitor induced colitis - Wikipedia

    en.wikipedia.org/wiki/Checkpoint_inhibitor...

    Checkpoint inhibitor induced colitis is an inflammatory condition affecting the colon , which is caused by cancer immunotherapy (checkpoint inhibitor therapy). Symptoms typically consist of diarrhea, abdominal pain and rectal bleeding. Less commonly, nausea and vomiting may occur, which may suggest the present of gastroenteritis. The severity ...

  3. Vedolizumab - Wikipedia

    en.wikipedia.org/wiki/Vedolizumab

    Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. [5] It binds to integrin α 4 β 7 ( LPAM-1 , lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7 ), [ 5 ] [ 6 ] blocking the α 4 ...

  4. Checkpoint inhibitor - Wikipedia

    en.wikipedia.org/wiki/Checkpoint_inhibitor

    Checkpoint inhibitor therapy is a form of cancer immunotherapy. ... Colitis (inflammation of the colon) occurs commonly. The precise mechanism is unknown, ...

  5. Ipilimumab - Wikipedia

    en.wikipedia.org/wiki/Ipilimumab

    Between 5.7 and 9.1% of individuals treated with ipilimumab develop checkpoint inhibitor induced colitis. [35] Individual cases of severe neurologic disorders following ipilimumab have been observed, including acute inflammatory demyelination polyneuropathy and an ascending motor paralysis, and myasthenia gravis. [36]

  6. Infliximab - Wikipedia

    en.wikipedia.org/wiki/Infliximab

    Infliximab is indicated for steroid refractory checkpoint inhibitor induced colitis, at a dose of 5 to 10 mg/kg. [ 41 ] Infliximab has been found to be a safe alternative treatment to a second dose of IVIG for Kawasaki Disease resistant to initial IVIG therapy, showing better outcomes in fever resolution and fewer severe adverse effects such as ...

  7. Immune checkpoint - Wikipedia

    en.wikipedia.org/wiki/Immune_checkpoint

    Cancer Therapy by Inhibition of Negative Immune Regulation (CTLA4, PD1) A2AR & A2BR: The Adenosine A2A receptor is regarded as an important checkpoint in cancer therapy because adenosine in the immune microenvironment, leading to the activation of the A2a receptor, is negative immune feedback loop and the tumor microenvironment has relatively high concentrations of adenosine. [27]

  1. Ads

    related to: checkpoint inhibitor for colitis